JP2009543807A - 抗ウイルス剤 - Google Patents

抗ウイルス剤 Download PDF

Info

Publication number
JP2009543807A
JP2009543807A JP2009519699A JP2009519699A JP2009543807A JP 2009543807 A JP2009543807 A JP 2009543807A JP 2009519699 A JP2009519699 A JP 2009519699A JP 2009519699 A JP2009519699 A JP 2009519699A JP 2009543807 A JP2009543807 A JP 2009543807A
Authority
JP
Japan
Prior art keywords
substituted
carbonylmethyl
methyl
amino
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009519699A
Other languages
English (en)
Japanese (ja)
Inventor
フランツ ウーリッヒ シュミッツ
クリストファー ドン ロバーツ
ロナルド コンラッド グリフィス
ヤノス ボツヤンスキ
サン ミン ファム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JP2009543807A publication Critical patent/JP2009543807A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2009519699A 2006-07-14 2007-07-12 抗ウイルス剤 Pending JP2009543807A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14
PCT/US2007/073391 WO2008008912A1 (en) 2006-07-14 2007-07-12 Antiviral agents

Publications (1)

Publication Number Publication Date
JP2009543807A true JP2009543807A (ja) 2009-12-10

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519699A Pending JP2009543807A (ja) 2006-07-14 2007-07-12 抗ウイルス剤

Country Status (13)

Country Link
EP (1) EP2044083A1 (pt)
JP (1) JP2009543807A (pt)
KR (1) KR20090033881A (pt)
CN (1) CN101490058A (pt)
AR (1) AR062258A1 (pt)
AU (1) AU2007272441A1 (pt)
BR (1) BRPI0714346A2 (pt)
CA (1) CA2657651A1 (pt)
MX (1) MX2009000513A (pt)
PE (1) PE20080427A1 (pt)
RU (1) RU2009105196A (pt)
TW (1) TW200813070A (pt)
WO (2) WO2008008912A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014500322A (ja) * 2010-12-22 2014-01-09 アッヴィ・インコーポレイテッド Ｃ型肝炎阻害剤およびその使用

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
AU2008248116A1 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of HCV infection
WO2011075615A1 (en) 2009-12-18 2011-06-23 Idenix Pharmaceuticals, Inc. 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
EP3248596B1 (en) 2015-01-20 2023-12-06 Tets, Viktor Veniaminovich Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
AU2018272839A1 (en) 2017-05-24 2019-12-19 Georgy Viktorovich Tets Fractionated antimicrobial compositions and use thereof
US11661431B2 (en) * 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
CN1798740A (zh) * 2003-06-04 2006-07-05 健亚生物科技公司 含氮的杂芳基衍生物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014500322A (ja) * 2010-12-22 2014-01-09 アッヴィ・インコーポレイテッド Ｃ型肝炎阻害剤およびその使用

Also Published As

Publication number Publication date
WO2008008907A3 (en) 2008-03-20
KR20090033881A (ko) 2009-04-06
BRPI0714346A2 (pt) 2013-03-19
EP2044083A1 (en) 2009-04-08
TW200813070A (en) 2008-03-16
WO2008008907A2 (en) 2008-01-17
RU2009105196A (ru) 2010-08-27
CN101490058A (zh) 2009-07-22
AU2007272441A1 (en) 2008-01-17
PE20080427A1 (es) 2008-06-11
AR062258A1 (es) 2008-10-29
AU2007272441A2 (en) 2009-03-19
MX2009000513A (es) 2009-03-09
WO2008008912A1 (en) 2008-01-17
CA2657651A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
JP2009543807A (ja) 抗ウイルス剤
JP2008526980A (ja) ウイルス感染症を治療するためのインドール誘導体
JP2008546802A (ja) ウイルスを治療するためのヘテロアリール誘導体
US20070032488A1 (en) 6-Membered aryl and heteroaryl derivatives for treating viruses
JP2010510245A (ja) 抗ウイルス化合物
JP2009544622A (ja) 多環式ウイルス阻害剤
BRPI0619733A2 (pt) compostos antivirais de n-(anel aromático de 6 membros)-amido
JP2010510246A (ja) アミド抗ウイルス化合物
KR20100056462A (ko) 항바이러스 화합물, 조성물 및 용도
US20080051384A1 (en) Antiviral agents
US20090197856A1 (en) Antiviral compounds
WO2010081149A1 (en) Anti-viral compounds, compositions, and methods of use